l1_dr sutarsa_1penulisan publikasi hasil penelitian - kih 19 oktober 2014.pptx

8/17/2019 L1_dr sutarsa_1Penulisan Publikasi Hasil Penelitian - KIH 19 Oktober 2014.pptx

1/25

Penulisan Publikasi Hasil

Penelitian

Nyoman Sutarsa


2/25

Who gets the credit?

In science, the credit goes to

the man who convinces the

world, not to the man towhom the idea first occurs.

─ Sir Francis Darwin


3/25

IMRAD

Introduction BackgroundLimitations of current evidenceStudy hypothesis

Methods DesignPatientsProceduresFollow-up

End-pointsAdditional analysesStatistical analysis

Results Baseline and procedural dataEarly outcomesMidtolong term outcomes !dditional analyses

"iscussion Summary of study findings#urrent research conte$tImplications of the present study !venues for further researchLimitations of the present study#onclusions


4/25

INTRD!"TIN

% What question (problem was studied

and what is your underlying

hypothesis!

% Include &'(E) &nown, 'nknown, the

(uestion, and then introduce the

E$perimental approach


5/25

INTRD!"TIN #cont$%

* +he nature and scope of the prolem

* +he gap or general prolem

* -revious findings. -ertinent literature

* +he method of investigation

* +he hypothesisresearch /uestion*signal


6/25

Remember the KUQE approach!

% &nown

% 'nknown

% (uestion

% E$perimental approach


7/25

Methods and Materials

"ow was the problem studied!

#he Methods section is o$ten the lessread section% but it is the most

important because allow us to

understand how the study was

conducted% thus gi&ing us an idea o$

the &alue o$ its results


8/25

Methods and Materials#cont$%

% "escrie with full details what was done to answer the

research /uestion

% In the eginning include a clear statement of study design)

0+he study was a doulelind, randomi1ed, parallel design2 designed to compare the efficacy and safety of 23

% Include also a sentence aout IRB approval, informed

consent, or compliance with animal welfare regulations)

0+he protocol was approved y the institutional reviewoard, and all patients gave informed consent 23


9/25

% State the protocolprocedures. Repeat the /uestion

and the aims)

04e tested the efficacy of drug 55 administered orally in a

dose of 55 mg, given 55 times daily for up to 55 months.3

0+here were 6 primary endpoints. +he first was eventfree

survival at 55 days, with an event defined as23

% "escrie materialsmethods or su7ects ade/uately% 4rite in a logical order 8usually chronological9

% "escrie analytical methods


10/25

Remember&

When writing the Methods%

always as' yoursel$ in e&ery step

:. 4hat has een done

6. ;ow it has een done


11/25

What were the $indings!

+he answer is in the Results.

Results

' d d IMRAD


12/25

'()anded IMRADalgorithm


Methods "esign-atients-rocedures>ollowup

Endpoints !dditional analysesStatistical analysis

)esults *aseline and procedural dataEarly outcomesMid-to-long term outcomesAdditional analyses



13/25

Results

% Logically answer the research /uestion

% >ocus on primary endpoint and on additional data

correlated to it

% #orrelate with the methods

% 'se data from this study only

% -resent all the representative data 8with e$act P values and confidence intervals9

% 'se tales, graphs, photographs, and drawings


14/25

Results

• Summari1e multiple outcomes in a figure or tale

• !void repetition of outcomes in figures, tales, or te$t

• Supplement rather than repeat data in visuals and

tales)

– "ata must agree within the section and with data

given in other sections and visuals

• M?S+ IM-?R+!@+LA) "o not discuss the findings or

interpret them /ualitatively


15/25

Discussion

What do these $indings mean!

)esults and Discussion sections shouldappear as written by two di$$erent

people+

' d d IMRAD


16/25

'()anded IMRADalgorithm


Methods "esign-atients-rocedures>ollowup

Endpoints !dditional analysesStatistical analysis

)esults *aseline and procedural dataEarly outcomesMid-to-long term outcomesAdditional analyses



17/25

% -resent the principles, relationships, and

generali1ations shown y the Results

% Briefly summari1e the Results in the first sentences

% But discuss C not thoroughly recapitulate C the

Results

% Include a eginning, middle, and end

% 4rite in present tense, active voiceD e$cept for thefindings, which are descried in past tense

% "iscuss this study only, in light of the others


18/25

• State the main finding, then discuss how technicalities might

have impacted it

• Interpret the magnitude of the main and any other findings

/ualitatively

• Reconcile the finding with those in other articles) a /ualitative

mini metaanalysis if you will

• E$plain possile mechanisms and confounders

• "evote space to discussion of a finding in proportion to the

certainty of its magnitude

• Introduce no new results

• E$plain any ma7or limitations


19/25

Discussion Structure

,*rie$ summary o$ the study $indings 8no need for

heading9

./urrent research conte0t 8use as heading9

12mplications o$ the present study 8use as heading9

3A&enues $or $urther research 8use as heading9

45imitations o$ the present study 8use as heading9

6/onclusions 8may use as heading9


20/25

A*STRA"T and TIT+'

A good abstract should

:.State the principal o7ectives and scope

of the investigation

6."escrie the methods employed


21/25

!stract

IMR!"

Introduction 8 !im9

Methods

Results

and

"iscussion 8#onclusions9


22/25

!stract

:. ItFs y far the most important part of the paper

8ecause most people only read this29

6. 4rite it before the rest of the paper, not after


23/25

!stract

. End with the main conclusion) state why or howitFs useful, not a rehash of what you found

J. It should e within a few words of the prescried

length 8usually etween 6KK and


24/25

+itleA good title should:. !ccurately, completely, and specifically identify the main

topic

6. Be unamiguous


25/25

Ackno,ledgement

All material ,ere summarised -romPresentation o- Worksho) on Scienti.c

Writing -or International Publication byDr Pandu Riono

l1_dr sutarsa_1penulisan publikasi hasil penelitian - kih 19 oktober 2014.pptx

Documents